Breaking News, Collaborations & Alliances

Evotec, Crohn’s & Colitis Foundation Partner on IBD Therapies

Leverages Evotec’s integrated R&D platform to advance drug discovery for two innovative drug targets.

Evotec SE, a life science company, has joined forces with the Crohn’s & Colitis Foundation, a non-profit organization focused on research and patient support for inflammatory bowel disease. Under the collaboration, Evotec teams up with the Foundation’s IBD Therapeutics Incubator program that facilitates collaboration between the foundation, academic researchers, and industry partners to translate basic research that was performed by academic researchers and identified by the foundation into ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters